Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2025-12-09 00:00:00 ET · period of report 2025-12-05 · accession 0001543174-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-09 | 2025-12-05 | ANIP | TANNENBAUM RENEE P | Dir | S - Sale | $81.15 | -1,800 | 25.2K | -7% | -$146.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-05 | S | D | 1,800 | $81.15 | 25,157 | D | — | — | (F1) The shares were sold in multiple trades at prices ranging from $81.14 to $81.16. The price reported above reflects the weighted average sales price. |